Literature DB >> 2298452

A probable sex difference in mutation rates in ornithine transcarbamylase deficiency.

C Bonaïti-Pellié1, A Pelet, H Ogier, J R Nelson, C Largillière, J Berthelot, J M Saudubray, A Munnich.   

Abstract

Ornithine transcarbamylase deficiency is an X-linked disease with possible manifestations in heterozygous females. Using segregation analysis in families from the literature pooled with a French series, the penetrance could be estimated to be 17% in heterozygous females (15% with severe and 2% with milder symptoms). Using these estimates, the proportion of sporadic cases among heterozygous females and hemizygous males could be derived. This proportion is 57% in females. In males, it depends on mutation rate values: assuming equal mutation rates in sperm and eggs, this proportion should be 40%. However, this value can be strongly rejected based on the proportion of isolated cases in male sibships. In both sets of data, segregation analysis provided no evidence for sporadic affected males, suggesting that there are virtually no mutations in eggs. The upper limit of the confidence interval, 0%-16%, can be taken as the maximum prior probability that an affected male occurs as the result of a new mutation in his mother's germ cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298452     DOI: 10.1007/bf00208933

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Genetic tests under incomplete ascertainment.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1959-03       Impact factor: 11.025

2.  A probable sex difference in some mutation rates.

Authors:  F Vogel
Journal:  Am J Hum Genet       Date:  1977-05       Impact factor: 11.025

Review 3.  Genetic counseling in sex linkage.

Authors:  N E Morton; J M Lalouel
Journal:  Birth Defects Orig Artic Ser       Date:  1979

Review 4.  Mammalian urea cycle enzymes.

Authors:  M J Jackson; A L Beaudet; W E O'Brien
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

5.  The marker (X) syndrome: a cytogenetic and genetic analysis.

Authors:  S L Sherman; N E Morton; P A Jacobs; G Turner
Journal:  Ann Hum Genet       Date:  1984-01       Impact factor: 1.670

Review 6.  Spontaneous mutation in man.

Authors:  F Vogel; R Rathenberg
Journal:  Adv Hum Genet       Date:  1975

7.  Carrier detection in a partially dominant X-linked disease: ornithine transcarbamylase deficiency.

Authors:  A Pelet; A Rotig; C Bonaïti-Pellié; D Rabier; V Cormier; E Toumas; D Hentzen; J M Saudubray; A Munnich
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

8.  X-linked dominant inherited diseases with lethality in hemizygous males.

Authors:  R Wettke-Schäfer; G Kantner
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  Natural history of symptomatic partial ornithine transcarbamylase deficiency.

Authors:  P C Rowe; S L Newman; S W Brusilow
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

10.  Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.

Authors:  M L Batshaw; M Msall; A L Beaudet; J Trojak
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

View more
  8 in total

1.  High male:female ratio of germ-line mutations: an alternative explanation for postulated gestational lethality in males in X-linked dominant disorders.

Authors:  G H Thomas
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.

Authors:  D Hentzen; A Pelet; D Feldman; D Rabier; J Berthelot; A Munnich
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

3.  Site specific screening for point mutations in ornithine transcarbamylase deficiency.

Authors:  D Feldmann; J M Rozet; A Pelet; D Hentzen; P Briand; P Hubert; C Largilliere; D Rabier; J P Farriaux; A Munnich
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

4.  Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 beta.

Authors:  G de Saint Basile; L D Notarangelo; C Bonaiti-Pellié; M Doussau; O Prolini; I W Craig; A Ugazio; C Griscelli; A Fischer
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

5.  Carrier detection in a partially dominant X-linked disease: ornithine transcarbamylase deficiency.

Authors:  A Pelet; A Rotig; C Bonaïti-Pellié; D Rabier; V Cormier; E Toumas; D Hentzen; J M Saudubray; A Munnich
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

6.  Single-strand conformational polymorphism and direct sequencing applied to carrier testing in families with ornithine transcarbamylase deficiency.

Authors:  M Y Tsai; R A Holzknecht; M Tuchman
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

7.  Paternal transmission and slow elimination of mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients.

Authors:  Sanae Numata; Eimei Harada; Yasuki Maeno; Isao Ueki; Yoriko Watanabe; Chieko Fujii; Takashi Yanagawa; Satoshi Takenaka; Toshiro Inoue; Shinkai Inoue; Terufumi Goushi; Tsutomu Yasutake; Toshihiko Mizuta; Makoto Yoshino
Journal:  J Hum Genet       Date:  2007-11-20       Impact factor: 3.172

8.  Ornithine transcarbamylase (OTC) deficiency in a female patient with a de nova deletion of the paternal X chromosome.

Authors:  R Slomski; I Braulke; C Behrend; E Schröder; J P Colombo; J Reiss
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.